Cargando…

ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer

There is a lack of reliable prognosis biomarker in the current treatment of colorectal cancer. The receptor-tyrosine-kinase-like orphan receptor 1 (ROR1) is overexpressed and associated with poor prognosis in certain tumors. This study aimed to explore the prognostic significance of ROR1 in colorect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jian-Kang, Zheng, Yu-Zhu, Liu, Xue-Sha, Gou, Qiheng, Ma, Rui, Guo, Cheng-Lin, Croce, Carlo M., Liu, Lunxu, Peng, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464834/ https://www.ncbi.nlm.nih.gov/pubmed/28427197 http://dx.doi.org/10.18632/oncotarget.15860

Ejemplares similares

ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
por: Zheng, Yu-Zhu, et al.
Publicado: (2016)

Profiling and bioinformatic analysis of circular RNA expression regulated by c-Myc
por: Gou, Qiheng, et al.
Publicado: (2017)

ROS1-fusion protein induces PD-L1 expression via MEK-ERK activation in non-small cell lung cancer
por: Liu, Zheng, et al.
Publicado: (2020)

Identification of RORγ as a favorable biomarker for colon cancer
por: Pan, Xiaofei, et al.
Publicado: (2021)

SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma
por: Chen, Cheng, et al.
Publicado: (2020)

ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy
por: Rebagay, Guilly, et al.
Publicado: (2012)

Functional Variants in Linc-ROR are Associated with mRNA Expression of Linc-ROR and Breast Cancer Susceptibility
por: Luo, Chenglin, et al.
Publicado: (2018)

Prognosis and Treatment of Metastatic Breast Cancer From A Real-World Scenario in China: A Retrospective Cohort Study
por: Xie, Yuxin, et al.
Publicado: (2022)

Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer
por: Tan, Shuangyan, et al.
Publicado: (2018)

ROR1 and ROR2 expression in pancreatic cancer
por: Liu, Dongli, et al.
Publicado: (2021)

The role of BRCA status on prognosis in patients with triple-negative breast cancer
por: Xie, Yuxin, et al.
Publicado: (2017)

ROR: Nuclear Receptor for Melatonin or Not?
por: Ma, Haozhen, et al.
Publicado: (2021)

RORα and REV-ERBα are Associated With Clinicopathological Parameters and are Independent Biomarkers of Prognosis in Gastric Cancer
por: Wang, Xiaoshan, et al.
Publicado: (2021)

Systematic evaluation of tumor microenvironment and construction of a machine learning model to predict prognosis and immunotherapy efficacy in triple-negative breast cancer based on data mining and sequencing validation
por: Gou, Qiheng, et al.
Publicado: (2022)

RORγt and RORα signature genes in human Th17 cells
por: Castro, Glenda, et al.
Publicado: (2017)

Distinct functions and prognostic values of RORs in gastric cancer
por: Gu, Feng, et al.
Publicado: (2020)

Digoxin, an Overlooked Agonist of RORγ/RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis
por: Lin, Weiwei, et al.
Publicado: (2023)

Long noncoding RNA ROR as a novel biomarker for progress and prognosis outcome in human cancer: a meta-analysis in the Asian population
por: Yang, Shengquan, et al.
Publicado: (2018)

LncRNAs as biomarkers for predicting radioresistance and survival in cancer: a meta-analysis
por: Xie, Yuxin, et al.
Publicado: (2022)

ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration
por: Ma, Sean S. Q., et al.
Publicado: (2016)

RORγt may Influence the Microenvironment of Thyroid Cancer Predicting Favorable Prognosis
por: Cunha, Lucas Leite, et al.
Publicado: (2020)

AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer
por: Li, Xubin, et al.
Publicado: (2022)

The Th17 immune response is controlled by the Rel–RORγ–RORγT transcriptional axis
por: Ruan, Qingguo, et al.
Publicado: (2011)

Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung
por: Wang, Walter Z., et al.
Publicado: (2021)

RORα and RORγ expression inversely correlates with human melanoma progression
por: Brożyna, Anna A., et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease: A Negative Risk Factor for Colorectal Cancer Prognosis
por: You, Jie, et al.
Publicado: (2015)

ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer
por: Gao, Song, et al.
Publicado: (2015)

New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome
por: Raivola, Juuli, et al.
Publicado: (2022)

Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value
por: Yu, Xiuchong, et al.
Publicado: (2020)

Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer
por: Peng, Wan-xin, et al.
Publicado: (2017)

Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C E, et al.
Publicado: (2016)

The Dichotomous Nature of AZ5104 (an EGFR Inhibitor) Towards RORγ and RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc
por: Wang, Ying-Nan, et al.
Publicado: (2022)

Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines
por: Wang, Hui-Li, et al.
Publicado: (2019)

ROR2 Is Epigenetically Regulated in Endometrial Cancer
por: Liu, Dongli, et al.
Publicado: (2021)

Pan-Tissue and -Cancer Analysis of ROR1 and ROR2 Transcript Variants Identify Novel Functional Significance for an Alternative Splice Variant of ROR1
por: John, Miya, et al.
Publicado: (2022)

lncRNA ROR and miR-125b Predict the Prognosis in Heart Failure Combined Acute Renal Failure
por: Xue, Qianlong, et al.
Publicado: (2022)

Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and ROR2 Kinase Domains
por: Bainbridge, Travis W., et al.
Publicado: (2014)

Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C. E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8574ecpph7eajv2dh61t94tmru